Inhibition of cell proliferation by a resveratrol analog in human pancreatic and breast cancer cells

Experimental and Molecular Medicine

Volumn 41, Issue 3, 2009, Pages 151-160

  Young, Bin Hong ^a   Hyo, Jin Kang ^a   Hee, Jeong Kim ^a   Rosen, Eliot M ^a   Dakshanamurthy, Sivanesan ^a   Rondanin, Riccardo ^b   Baruchello, Riccardo ^b   Grisolia, Giuseppina ^b   Daniele, Simoni ^b   Bae, Insoo ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Antineoplastic agents; Breast neoplasms; Cell cycle; cis 3,4 ,5 trimethoxy 3 hydroxystilbene; Pancreatic neoplasms; Phytogenic; Resveratrol; Tubulin

Indexed keywords

3,4',5 TRIMETHOXY 3' HYDROXYSTILBENE; AURORA B KINASE; BUB1 RELATED PROTEIN; COLCHICINE; CYCLIN B; HISTONE H3; RESVERATROL; TUBULIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MICROTUBULE ASSEMBLY; PANCREAS CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 65949119115     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2009.41.3.018     Document Type: Article

References (38)

1. Adams RR, Carmena M, Earnshaw WC. Chromosomal passengers and the aurora ABCs of mitosis. Trends Cell Biol 2001;11:49-54 (Pubitemid 32144751)
2. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL. Resveratrol: a review of pre-clinical studies for human cancer prevention. Toxicol Appl Pharmacol 2007;224:274-283 (Pubitemid 47575677)
3. Azios NG, Krishnamoorthy L, Harris M, Cubano LA, Cammer M, Dharmawardhane SF. Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells. Neoplasia 2007;9:147-158 (Pubitemid 46318373)
4. Bae I, Fan S, Meng Q, Rih JK, Kim HJ, Kang HJ, Xu J, Goldberg ID, Jaiswal AK, Rosen EM. BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res 2004;64:7893-7909 (Pubitemid 39446923)
5. Bae I, Rih JK, Kim HJ, Kang HJ, Haddad B, Kirilyuk A, Fan S, Avantaggiati ML, Rosen EM. BRCA1 regulates gene expression for orderly mitotic progression. Cell Cycle 2005;11:1641-1666 (Pubitemid 41609148)
6. Bai R, Pei XF, Boye O, Getahun Z, Grover S, Bekisz J, Nguyen NY, Brossi A, Hamel E. Identification of cysteine 354 of β-tubulin as part of the binding site for the A ring of colchicine. J Biol Chem 1996;271:12639-12645 (Pubitemid 26160939)
7. Berendsen HJC, Postma JPM, Vangunsteren WF, Dinola A, Haak AR. Molecular-dynamics with coupling to an external bath. J Chem Phys 1984;81:3684-3690
8. Buzdar AU. Preoperative Chemotherapy Treatment of Breast Cancer-A Review. Cancer 2007;110:2394-2407 (Pubitemid 350174924)
9. Case DA, Darden TA, Cheatham TE, Simmerling CL, Wang J, Duke RE, Luo R, Merz KM, Pearlman DA, Crowley M, Walker RC, Zhang W, Wang B, Hayik S, Roitberg A, Seabra G, Wong KF, Paesani F, Wu X, Brozell S, Tsui V, Gohlke H, Yang L, Tan C, Mongan J, Hornak V, Cui G, Beroza P, Mathews DH, Schafmeister C, Ross WS, Kollman PA, AMBER 9, 2006, University of California, San Francisco.
10. Chen RH. BubR1 is essential for kinetochore localization of other spindle checkpoint proteins and its phosphorylation requires Mad1. J Cell Biol 2002;158:487-496
11. Cuschieri L, Nguyen T, Vogel J. Control at the cell center: the role of spindle poles in cytoskeletal organization and cell cycle regulation. Cell Cycle 2007;6:2788-94 Darden T, York D, Pedersen L. Particle mesh Ewald: an N.Log(N) method for Ewald sums in large systems. J Chem Phys 1993;98:10089-10092 (Pubitemid 350277171)
12. Ding XZ, Adrian TE. Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Pancreas 2002;25:71-76
13. Epelbaum R, Rosenblatt E, Nasrallah S, Faraggi D, Gaitini D, Mizrahi S, Kuten A. Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer. J Surg Oncol 2002;81:138-143 (Pubitemid 35253625)
14. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA Jr, Vreven T, Kudin KN, Burant JC. Gaussian 03, 2003, Gaussian, Inc., Pittsburgh, PA.
15. Gorman AM, Bonfoco E, Zhivotovsky B, Orrenius S, Ceccatelli S. Cytochrome c release and caspase-3 activation during colchicine-induced apoptosis of cerebellar granule cells. Eur J Neurosci 1999;11:1067-1072 (Pubitemid 29106067)
16. Hanson RN, Lee CY, Friel CJ, Dilis R, Hughes A, DeSombre ER. Synthesis and evaluation of 17α-20E-21-(4-substituted phenyl)-19-norpregna-1,3,5(10) ,20-tetraene-3,17β-diols as probes for the estrogen receptor hormone binding domain. J Med Chem 2003;46:2865-2876
17. Ikegami R, Zhang J, Rivera-Bennetts AK, Yager TD. Activation of the metaphase checkpoint and an apoptosis programme in the early zebrafish embryo, by treatment with the spindle-destabilising agent nocodazole. Zygote 1997;5:329-350 (Pubitemid 127594322)
18. Ishii H, Okada S, Tokuuye K, Nose H, Okusaka T, Yoshimori M, Nagahama H, Sumi M, Kagami Y, Ikeda H. Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma. Cancer 1997;79:1516-1520 (Pubitemid 27154781)
19. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Menta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-220 (Pubitemid 127696281)
20. Jimeno A, Hidalgo M. Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer. Mol Cancer Ther 2006;5:787-796 (Pubitemid 43724577)
21. Kim EY, Hong YB, Go SH, Lee B, Jung SC. Downregulation of neurotrophic factors in the brain of a mouse model of Gaucher disease; implications for neuronal loss in Gaucher disease. Exp Mol Med 2006;38:348-356 (Pubitemid 44351429)
22. Kim R, Saif MW. Is there an Optimal Neoadjuvant Therapy for Locally Advanced Pancreatic Cancer? J Pancreas 2007;8:279-288
23. Kong Y, Grembecka J, Edler MC, Hamel E, Mooberry SL, Sabat M, Rieger J, Brown ML. Structure-based discovery of a boronic acid bioisostere of combretastatin A-4. Chem Biol 2005;12:1007-1014 (Pubitemid 41338811)
24. Kuroiwa Y, Nishikawa A, Kitamura Y, Kanki K, Ishii Y, Umemura T, Hirose M. Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters. Cancer Lett 2006;241:275-280 (Pubitemid 44163037)
25. Lawrence NJ, McGown AT. The chemistry and biology of antimitotic chalcones and related enone systems. Curr Pharm Des 2005;11:1679-1693 (Pubitemid 40668144)
26. Le Corre L, Chalabi N, Delort L, Bignon YJ, Bernard-Gallon DJ. Resveratrol and breast cancer chemoprevention: molecular mechanism. Mol Nutr Food Res 2005;49:462-471 (Pubitemid 40780393)
27. Lockhart AC, Rothenberg ML, Berlin JD. Treatment for pancreatic cancer: current therapy and continued progress. Gastroenterology 2005;128:1642-1654 (Pubitemid 40692557)
28. Nogales E, Wolf SG, Downing KH. Structure of the alpha beta tubulin dimer by electron crystallography. Nature 1998;391:199-203 (Pubitemid 28092482)
29. Ota T, Suto S, Katayama H, Han ZB, Suzuki F, Maeda M, Tanino M, Terada Y, Tatsuka M. Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability. Cancer Res 2002;62:5168-5177
30. Provinciali M, Re F, Donnini A, Orlando F, Bartozzi B, Di Stasio G, Smorlesi A. Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Int J Cancer 2005;115:36-45 (Pubitemid 40559666)
31. Rarey M, Kramer B, Lengauer T, Klebe G. A fast flexible docking method using an incremental construction algorithm. J Mol Biol 1996;261:470-489 (Pubitemid 26335901)
32. Ravelli RB, Gigant B, Curmi PA, Jourdain I, Lachkar S, Sobel A, Knossow M. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature 2004;428:198-202 (Pubitemid 38374318)
33. Rich T, Harris J, Abrams R, Erickson B, Doherty M, Paradelo J, Small W Jr, Safran H, Wanebo HJ. Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12. Am J Clin Oncol 2004;27:51-56
34. Roberti M, Pizzirani D, Simoni D, Rondanin R, Baruchello R, Bonora C, Buscemi F, Grimaudo S, Tolomeo M. Synthesis and Biological Evaluation of Resveratrol and Analogues as Apoptosis-Inducing Agents. J Med Chem 2003;46:3546-3554 (Pubitemid 36909831)
35. Sanchez I, Dynlacht BD. New insights into cyclins, CDKs, and cell cycle control. Semin Cell Dev Biol 2005;16:311-321 (Pubitemid 40504220)
36. Tao W, South VJ, Zhang Y, Davide JP, Farrell L, Kohl NE, Sepp-Lorenzino L, Lobell RB. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly ckeckpoint and mitotic slippage. Cancer Cell 2005;8:49-59 (Pubitemid 40991814)
37. Weaver BAA, Cleveland DW. Decoding the links between mitosis, cancer, and chemotherapy: the mitotic checkpoint, adaptation, and cell death. Cancer Cell 2005;8:7-12 (Pubitemid 40991810)
38. Wei Y, Yu L, Bowen J, Gorovsky MA, Allis CD. Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell 1999;97:99-109 (Pubitemid 29165893)